Cloning and Protein Purification of 2201LBD Mutants
MEDS Basic Medicine · 2023
DOI: 10.23977/medbm.2023.010205 ↗Kurz gefasst
Fachartikel in der Zeitschrift MEDS Basic Medicine, 2023.
Abstract (Originalsprache)
In this study, we employed molecular cloning techniques involving PCR, DNA agarose gel electrophoresis, and restriction enzyme digestion to successfully clone 2201LBD mutants with point mutations at residues 172 and 142. Following enzymatic digestion of DNA and plasmid vectors using restriction enzymes, the T4 DNA ligase was used to ligate the modified DNA fragments into the vectors. Subsequently, the resulting constructs were transformed into Escherichia coli BL21 (DE3) strains for protein expression and purification. These engineered mutants, 2201LBD-Y172A and 2201LBD-R142A, were purified to facilitate subsequent experimental investigations.
Zitieren
APA
(2023). Cloning and Protein Purification of 2201LBD Mutants. MEDS Basic Medicine. https://doi.org/10.23977/medbm.2023.010205
Vancouver
Cloning and Protein Purification of 2201LBD Mutants. MEDS Basic Medicine. 2023. doi:10.23977/medbm.2023.010205
BibTeX
@article{euvimed2023,
title = {Cloning and Protein Purification of 2201LBD Mutants},
journal = {MEDS Basic Medicine},
year = {2023},
doi = {10.23977/medbm.2023.010205}
}
EUVIMED